EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma

Xin Liu iD, Meng Fu iD, Daqing Xia, Zimei Ji, Nana Hu, Zaijun Leng, Wang Xie, Yuan Fang, Junqiang Zhang iD

Journal of Oncology · 05.10.2022 · 2022 · 1-10

DOI: 10.1155/2022/8767333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology, erschienen am 05.10.2022. Verfasst von Xin Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bengbu Medical College, Bengbu, 233030 Anhui, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central University, Natural Science Foundation of Anhui Province, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Family with sequence similarity 83, member A (FAM83A) plays an essential and fundamental role in the proliferation, progression, and apoptosis of many malignant tumors, including lung cancer. This study aimed to determine the expression pattern of FAM83A in lung adenocarcinoma (LUAD) and its correlation with the prognosis of cancer and the survival of the patients. Bioinformatics analysis, immunohistochemistry, and Western blotting were used to explore and detect the expression of FAM83A in LUAD cells. The mechanism of FAM83A in proliferation and migration was examined. The correlation between FAM83A expression and survival rate was assessed by the Kaplan-Meier and Cox regression. FAM83A expression was elevated in LUAD tissues and was related to shorter overall survival ( P < 0.05 ). A significant increase in FAM83A protein was observed in the LUAD tissue ( P < 0.05 ). Compared with patients with early-stage tumors (stage I-II), those with advanced stage tumors (stage III-IV) had significantly higher FAM83A expression levels ( P < 0.05 ). Downregulation of FAM83A led to a reduction in cell proliferation, a decrease in migration ability, and diminished epithelial-mesenchymal transition (EMT) in the lung cancer cell lines. Overexpression of FAM83A was associated with early lymph node metastasis and poor overall survival among LUAD patients. The findings indicated that FAM83A may play a critical role in promoting the LUAD progression and thus might serve as a novel prognostic marker in LUAD.

Autor:innen und Institutionen

  • Bengbu Medical College, Bengbu, 233030 Anhui, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
  • Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
  • University of Science and Technology of China, Hefei 230026, China.

ORCID-Profile: Xin Liu, Meng Fu, Junqiang Zhang

Förderung

  • Fundamental Research Funds for the Central University
  • Natural Science Foundation of Anhui Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, X., Fu, M., Xia, D., Ji, Z., Hu, N., Leng, Z., Xie, W., Fang, Y., & Zhang, J. (2022). Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma. Journal of Oncology, 2022, 1-10. https://doi.org/10.1155/2022/8767333

Vancouver

Liu X, Fu M, Xia D, Ji Z, Hu N, Leng Z, et al. Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma. Journal of Oncology. 2022;2022:1-10. doi:10.1155/2022/8767333

BibTeX
@article{Liu2022,
  author = {Liu, Xin and Fu, Meng and Xia, Daqing and Ji, Zimei and Hu, Nana and Leng, Zaijun and Xie, Wang and Fang, Yuan and Zhang, Junqiang},
  title = {Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma},
  journal = {Journal of Oncology},
  year = {2022},
  volume = {2022},
  pages = {1--10},
  doi = {10.1155/2022/8767333}
}
Kostenlos starten →